HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ana Luiza Maia Selected Research

Iodide Peroxidase (Deiodinase)

5/2022Low Inflammatory Stimulus Increases D2 Activity and Modulates Thyroid Hormone Metabolism during Myogenesis In Vitro.
4/2022Type 2 Deiodinase Thr92Ala Polymorphism Is Not Associated with Cognitive Impairment in Older Adults: A Cross-Sectional Study.
1/2020Decreased expression of the thyroid hormone-inactivating enzyme type 3 deiodinase is associated with lower survival rates in breast cancer.
11/2017Consumptive Hypothyroidism: Case Report of Hepatic Hemangioendotheliomas Successfully Treated with Vincristine and Systematic Review of the Syndrome.
3/2016MAPK and SHH pathways modulate type 3 deiodinase expression in papillary thyroid carcinoma.
1/2014The rs225017 polymorphism in the 3'UTR of the human DIO2 gene is associated with increased insulin resistance.
9/2012Increased type 3 deiodinase expression in papillary thyroid carcinoma.
12/2010Type 2 iodothyronine deiodinase levels are higher in slow-twitch than fast-twitch mouse skeletal muscle and are increased in hypothyroidism.
9/2010Association of the type 2 deiodinase Thr92Ala polymorphism with type 2 diabetes: case-control study and meta-analysis.
7/2008Type 2 iodothyronine deiodinase is highly expressed in medullary thyroid carcinoma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ana Luiza Maia Research Topics

Disease

19Neoplasms (Cancer)
01/2022 - 06/2003
17Thyroid Neoplasms (Thyroid Cancer)
01/2022 - 07/2008
9Neoplasm Metastasis (Metastasis)
12/2020 - 06/2009
6Hyperthyroidism
10/2016 - 02/2004
6Type 2 Diabetes Mellitus (MODY)
03/2014 - 06/2005
5Hypothyroidism
01/2021 - 03/2006
5Papillary Thyroid Cancer
01/2018 - 06/2005
5Multiple Endocrine Neoplasia Type 2a (MEN 2)
10/2016 - 06/2003
4Insulin Resistance
03/2014 - 06/2005
3Myocardial Infarction
01/2017 - 06/2013
3Thyrotoxicosis
10/2016 - 02/2004
2Breast Neoplasms (Breast Cancer)
01/2022 - 01/2020
2Thyroid Nodule (Nodule, Thyroid)
01/2022 - 12/2008
2Euthyroid Sick Syndromes (Euthyroid Sick Syndrome)
01/2017 - 01/2012
2Graves Disease (Basedow Disease)
10/2016 - 10/2004
2Adenoma (Adenomas)
10/2016 - 06/2005
2Goiter
10/2016 - 02/2004
2Hypertension (High Blood Pressure)
06/2007 - 11/2005
1Inflammation (Inflammations)
05/2022
1Cognitive Dysfunction
04/2022
1Thyroid Diseases (Thyroid Disease)
01/2022
1Pancreatic Neoplasms (Pancreatic Cancer)
12/2020
1Hypocalcemia
01/2018
1Hemangioendothelioma
11/2017
1Graves Ophthalmopathy
10/2016
1Hirschsprung Disease (Hirschsprung's Disease)
01/2016
1Adrenal Insufficiency (Adrenal Gland Hypofunction)
05/2014
1Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis)
05/2014
1Pheochromocytoma
03/2014
1Cardiomyopathies (Cardiomyopathy)
06/2013
1Heart Failure
06/2013
1Cardiotoxicity
06/2013
1Carcinoma (Carcinomatosis)
01/2013
1Carcinogenesis
01/2013
1Inborn Genetic Diseases (Disease, Hereditary)
11/2012
1Critical Illness (Critically Ill)
01/2012
1Pathologic Processes
06/2011
1Chronic Disease (Chronic Diseases)
05/2011
1Cushing Syndrome
02/2010
1Lymphatic Metastasis
12/2008
1Pancreatitis
11/2008
1Disease Susceptibility (Diathesis)
07/2007

Drug/Important Bio-Agent (IBA)

16Iodide Peroxidase (Deiodinase)IBA
05/2022 - 06/2005
10EnzymesIBA
05/2022 - 06/2005
10Thyroid HormonesIBA
01/2020 - 03/2006
5IodineIBA
11/2021 - 02/2004
5Codon (Codons)IBA
10/2016 - 06/2003
4Calcitonin (Calcitonin, Eel)FDA LinkGeneric
01/2018 - 08/2008
4Antithyroid Agents (Antithyroid Drugs)IBA
10/2016 - 02/2004
4Proteins (Proteins, Gene)FDA Link
08/2010 - 06/2005
3DNA (Deoxyribonucleic Acid)IBA
01/2018 - 11/2008
3ThyroglobulinFDA Link
11/2017 - 08/2010
3AntibodiesIBA
11/2017 - 10/2004
3Messenger RNA (mRNA)IBA
01/2016 - 06/2005
3Thyrotropin Receptors (Thyrotropin Receptor)IBA
02/2012 - 02/2004
2Mitogen-Activated Protein KinasesIBA
01/2022 - 01/2013
2CalciumIBA
01/2018 - 11/2008
2Acetylcysteine (Siran)FDA LinkGeneric
01/2017 - 12/2014
23' Untranslated Regions (3' UTR)IBA
01/2016 - 01/2014
2Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
03/2014 - 08/2010
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2014 - 08/2010
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
03/2014 - 08/2010
2Glucose (Dextrose)FDA LinkGeneric
03/2014 - 03/2007
2Iodothyronine Deiodinase Type IIIBA
03/2014 - 06/2005
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2013 - 07/2007
2Triiodothyronine (Liothyronine)FDA LinkGeneric
09/2012 - 05/2011
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2022
1Phenobarbital (Luminal)FDA Link
01/2022
1Tumor Biomarkers (Tumor Markers)IBA
12/2020
1AntigensIBA
12/2020
1Biomarkers (Surrogate Marker)IBA
12/2020
1CarbohydratesIBA
12/2020
1RNA (Ribonucleic Acid)IBA
01/2020
1Sorafenib (BAY 43-9006)FDA Link
01/2019
1Parathyroid Hormone (Parathormone)IBA
01/2018
1anti-thyroglobulinIBA
11/2017
1Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA
11/2017
1Vincristine (Oncovin)FDA LinkGeneric
11/2017
1AntioxidantsIBA
12/2014
1SteroidsIBA
05/2014
1CatecholaminesIBA
03/2014
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
03/2014
1Genetic Markers (Genetic Marker)IBA
03/2014
1Tissue Inhibitor of Metalloproteinase-2IBA
03/2014
1Matrix Metalloproteinases (MMPs)IBA
03/2014
1vandetanib (ZD6474)IBA
06/2013
1Troponin T (Troponin T1)IBA
06/2013
1Pharmaceutical PreparationsIBA
06/2013
1CateninsIBA
01/2013
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2013
1Adrenal Cortex Hormones (Corticosteroids)IBA
02/2010
1Hydrocortisone (Cortisol)FDA LinkGeneric
02/2010

Therapy/Procedure

13Therapeutics
01/2022 - 02/2004
3Thyroidectomy
01/2019 - 01/2017
1Radiofrequency Ablation
01/2022
1Neoadjuvant Therapy
01/2019
1Drug Therapy (Chemotherapy)
11/2017
1Adrenalectomy
05/2014
1Glycemic Control
03/2014
1Operative Surgical Procedures
12/2008